
Lo-Platt 75 Tablet
Marketer
Paras Impex
Salt Composition
Clopidogrel (75mg)
Overview Lo-Platt 75 Tablet
CardioGuard 75mg tablets are antiplatelet agents, preventing the formation of dangerous blood clots within your circulatory system. This reduces your risk of stroke and heart attack, making it a common preventative medication. CardioGuard 75mg is prescribed for individuals at elevated risk of cardiovascular events. This includes those with peripheral artery disease (circulatory issues from narrowed arteries), recent heart attack or stroke, abnormal heart rhythms, and post-certain cardiac procedures like angioplasty. It's also used alongside other medications to manage heart attacks and unstable angina. This medication can be taken with or without food, consistently at the same time daily. Continued use is vital, even if feeling well; discontinuation increases the risk of cardiac events. The most frequent side effect is increased bleeding, manifesting as bruising, nosebleeds, hematuria (blood in urine), melena (dark stools), or heavier menstrual bleeding. Wounds may bleed longer than normal. While typically mild and self-limiting, persistent or concerning bleeding necessitates immediate medical attention. This medication is contraindicated in individuals with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage). Inform your physician of any bleeding disorders, recent significant injuries, or upcoming surgeries before commencing treatment. CardioGuard 75mg may require temporary discontinuation prior to scheduled procedures.
Primary Ingredients of Lo-Platt 75 Tablet
No information provided. Unable to rephrase.
Uses of Lo-Platt 75 Tablet
Cardiovascular event prophylaxis
Major Benefits of Lo-Platt 75 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Lo-Platt 75 Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, though consistent timing is recommended.
Common Side effects of Lo-Platt 75 Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Lo-Platt 75 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Lo-Platt 75 Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. While Lo-Platt 75 may be administered with or without food, consistent timing is recommended.
How Lo-Platt 75 Tablet works:
CardioGuard 75mg tablets offer antiplatelet protection. Their mechanism inhibits platelet aggregation, thus reducing the risk of dangerous clot development and consequently, the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Lo-Platt 75 Tablet and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Lo-Platt 75 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of Lo-Platt 75 Tablet while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Lo-Platt 75 Tablet.
KidneySAFE IF PRESCRIBED
Lo-Platt 75 Tablets pose no safety concerns for patients with kidney impairment; no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
Lo-Platt 75 Tablets pose no safety concerns for individuals with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Lo-Platt 75 Tablet :
Should you forget to take a Lo-Platt 75 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Lo-Platt 75 Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alpha esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
